Literature DB >> 16417151

Validity of optical device lipometer and bioelectric impedance analysis for body fat assessment in men and women.

Toivo Jürimäe1, Karl Sudi, Jaak Jürimäe, Doris Payerl, Reinhart Möller, Erwin Tafeit.   

Abstract

The aims of this study were to validate different subcutaneous adipose tissue layers (SAT-layers) measured by lipometer for body fat percentage (BF%) assessment with dual-energy X-ray absorptiometry (DXA) and to compare the validity of lipometer and bioelectrical impedance analysis (BIA). The subjects were 21 male (18-60 years) and 19 female (23-54 years) healthy Estonian volunteers. SAT-layers were measured by lipometer using 15 standardized SAT-layers. Sum of arms, legs and trunk SAT-layers were calculated and compared with arms, legs and trunk fat percentage measured by DXA. BF% was calculated by BIA using the equations of Lukaski et al. and Chumlea et al. for both genders and the equations of Segal et al. for males and Van Loan and Mayclin for females. BF% measured by DXA was significantly higher than calculated by Lukaski et al. and Chumlea et al. in both genders. The correlation was highest between the BF% measured by DXA and using Segal et al. equation in males (r = 0.94) and Van Loan and Mayclin equation in females (r = 0.84). High relationship was observed between BF% measured by DXA and sum of 15 SAT-layers (r = 0.88 in males and r = 0.91 in females). Stepwise multiple regression analysis indicated that two selected SAT-layers explained 85.9% and 86.7% (R2 x 100) of the total variance in BF% measured by DXA in males and females, respectively: [BF% = 1.308 neck + 0.638 hip + 6.971 (males; SEE = 2.59) and BF% = 1.152 hip + 1.797 calf + 12.347 (females; SEE = 3.46)]. In conclusion, lipometer and BIA give a similar mean estimation of BF% when compared with DXA. However, there is a wide range of variance for the upper and lower limits of agreement between the methods, and the methods are not interchangeable. Lipometer seems to be superior to BIA.

Entities:  

Mesh:

Year:  2005        PMID: 16417151

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  6 in total

1.  Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

Authors:  Elisabeth Wehr; Reinhard Möller; Renate Horejsi; Albrecht Giuliani; Daisy Kopera; Natascha Schweighofer; Andrea Groselj-Strele; Thomas R Pieber; Barbara Obermayer-Pietsch
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Using body mass index ignores the intensive training of elite special force personnel.

Authors:  Erwin Tafeit; Gerhard Cvirn; Manfred Lamprecht; Markus Hohensinn; Reinhard Moeller; Michael Hamlin; Renate Horejsi
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-13

3.  Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates.

Authors:  M Eder; B Csapo; C Wadsack; J Haas; P M Catalano; G Desoye; M N M van Poppel
Journal:  Int J Obes (Lond)       Date:  2015-09-21       Impact factor: 5.095

4.  Detecting body fat-A weighty problem BMI versus subcutaneous fat patterns in athletes and non-athletes.

Authors:  Renate Kruschitz; Sandra J Wallner-Liebmann; Michael J Hamlin; Maximilian Moser; Bernhard Ludvik; Wolfgang J Schnedl; Erwin Tafeit
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

5.  The anticoagulant effects of ethyl pyruvate in whole blood samples.

Authors:  Harald Haidl; Axel Schlagenhauf; Angelika Krebs; Harald Plank; Willibald Wonisch; Vera Fengler; August Fiegl; Gerd Hörl; Martin Koestenberger; Thomas Wagner; Erwin Tafeit; Gerhard Cvirn; Seth Hallström
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

6.  Non-invasive cooling wear as an effective means of reducing subcutaneous adipose tissue mass: an in-vivo study.

Authors:  Hanna Luze; Andrzej Hecker; Sebastian Philipp Nischwitz; Marlies Schellnegger; Michael Kohlhauser; Alexander Draschl; Clemens Müllegger; Lars-Peter Kamolz; Petra Kotzbeck
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.